119 related articles for article (PubMed ID: 35751131)
1. PITRM1 interaction studies with amyloidogenic nonapeptide mutants of familial Alzheimer's disease.
Wilson Alphonse CR; Rajesh Kannan R; Nagarajan N
J Biomol Struct Dyn; 2023; 41(12):5660-5671. PubMed ID: 35751131
[TBL] [Abstract][Full Text] [Related]
2. Functional requirement for human pitrilysin metallopeptidase 1 arginine 183, mutated in amyloidogenic neuropathy.
Smith-Carpenter JE; Alper BJ
Protein Sci; 2018 Apr; 27(4):861-873. PubMed ID: 29383861
[TBL] [Abstract][Full Text] [Related]
3. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
Chong SH; Yim J; Ham S
Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
[TBL] [Abstract][Full Text] [Related]
4. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
5. Insights in the structural understanding of amyloidogenicity and mutation-led conformational dynamics of amyloid beta (Aβ) through molecular dynamics simulations and principal component analysis.
Raghavan SS; Iqbal S; Ayyadurai N; Gunasekaran K
J Biomol Struct Dyn; 2022 Aug; 40(12):5577-5587. PubMed ID: 33438527
[TBL] [Abstract][Full Text] [Related]
6. Effects of Familial Alzheimer's Disease Mutations on the Folding Free Energy and Dipole-Dipole Interactions of the Amyloid β-Peptide.
Davidson DS; Kraus JA; Montgomery JM; Lemkul JA
J Phys Chem B; 2022 Oct; 126(39):7552-7566. PubMed ID: 36150020
[TBL] [Abstract][Full Text] [Related]
7. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
[TBL] [Abstract][Full Text] [Related]
8. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
9. Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.
Krone MG; Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
J Mol Biol; 2008 Aug; 381(1):221-8. PubMed ID: 18597778
[TBL] [Abstract][Full Text] [Related]
10. Effects of familial mutations on the monomer structure of Aβ₄₂.
Lin YS; Pande VS
Biophys J; 2012 Dec; 103(12):L47-9. PubMed ID: 23260058
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Schilling S; Pradhan A; Heesch A; Helbig A; Blennow K; Koch C; Bertgen L; Koo EH; Brinkmalm G; Zetterberg H; Kins S; Eggert S
Acta Neuropathol Commun; 2023 Jun; 11(1):87. PubMed ID: 37259128
[TBL] [Abstract][Full Text] [Related]
12. Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration.
Brunetti D; Torsvik J; Dallabona C; Teixeira P; Sztromwasser P; Fernandez-Vizarra E; Cerutti R; Reyes A; Preziuso C; D'Amati G; Baruffini E; Goffrini P; Viscomi C; Ferrero I; Boman H; Telstad W; Johansson S; Glaser E; Knappskog PM; Zeviani M; Bindoff LA
EMBO Mol Med; 2016 Mar; 8(3):176-90. PubMed ID: 26697887
[TBL] [Abstract][Full Text] [Related]
13. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
[TBL] [Abstract][Full Text] [Related]
14. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
[TBL] [Abstract][Full Text] [Related]
15. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
Shuaib S; Saini RK; Goyal D; Goyal B
J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
[TBL] [Abstract][Full Text] [Related]
16. The role of the half-turn in determining structures of Alzheimer's Aβ wild-type and mutants.
Hayward S; Kitao A
J Struct Biol; 2021 Dec; 213(4):107792. PubMed ID: 34481077
[TBL] [Abstract][Full Text] [Related]
17. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
Baumketner A; Krone MG; Shea JE
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165
[TBL] [Abstract][Full Text] [Related]
18. Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions.
Tarus B; Straub JE; Thirumalai D
J Mol Biol; 2008 Jun; 379(4):815-29. PubMed ID: 18479708
[TBL] [Abstract][Full Text] [Related]
19. Familial Alzheimer's Disease-Related Mutations Differentially Alter Stability of Amyloid-Beta Aggregates.
Rezaei-Ghaleh N; Amininasab M; Giller K; Becker S
J Phys Chem Lett; 2023 Feb; 14(6):1427-1435. PubMed ID: 36734539
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
